Adverse Cutaneous Reactions to Psychotropic Drugs: A Review

Authors

  • Filipa Novais Centro hospitalar Lisboa Norte, EPE Faculdade de Medicina de Lisboa
  • João Pedro Vasconcelos Centro hospitalar Lisboa Norte, EPE Faculdade de Ciências Médicas de Lisboa
  • Diogo Telles-Correia Centro Hospitalar Lisboa Norte, EPE Faculdade de Medicina de Lisboa

DOI:

https://doi.org/10.25752/psi.5991

Keywords:

Psychotropic Drugs, Cutaneous Adverse Reactions, Antidepressants, Antipsychotics, Benzodiazepines, Mood Stabilizers, Anticonvulsants, Antidementia.

Abstract

Introduction: Psychotropic drugs are often implicated in cutaneous adverse drug reactions. While most of these reactions have a benign character, it is still important, however, to consider its role in the increasing stigma and treatment adherence. A small number of the cutaneous adverse drug reactions can develop into serious and potentially fatal conditions.

Objectives: This article aims to review the most common cutaneous adverse drug reactions in patients taking psychotropic drugs.

Methods: In this study, a search was carried out in the MEDLINE database for English language articles published , from 1999 to 2014, using as keywords: psychiatric, psychotropic, cutaneous, adverse reaction, antidepressive agents, antipsychotics, benzodiazepines, mood stabilizers, anticonvulsant, dementia. Information available from the Portuguese regulatory and supervising agency (Infarmed) was also included.

Results: 121 articles were found with reference to cutaneous adverse drug reactions associated with psychotropic drugs. The drugs most frequently reported as associated with such adverse effects were anticonvulsants used as mood stabilizers, followed by the antipsychotics . The antidementia drugs were rarely associated with serious cutaneous adverse reactions.

Discussion and Conclusion: Cutaneous drug adverse reactions are common in psychiatric clinical practice and typically are minor in severity. The most severe reactions are most often associated with the use of mood stabilizing medications. Some of these side effects can be solved with reduction or drug discontinuation. More severe cases should be referred to a specialist in dermatology.

Author Biography

Filipa Novais, Centro hospitalar Lisboa Norte, EPE Faculdade de Medicina de Lisboa

Interna de Psiquiatria do Hospital de Santa Maria

Docente livre da Faculdade de Medicina de Lisboa

Published

2015-06-01

Issue

Section

Review Articles